Results 1 to 10 of about 14,693 (147)
Case report and literature review: the effect of surgical management in intrathoracic pseudomyxoma peritonei [PDF]
Frontiers in SurgeryBackgroundIntrathoracic metastasis in patients with pseudomyxoma peritonei is extremely rare and carries a poor prognosis. No standard treatment recommendations have been established, and it remains unclear whether surgical treatment can improve the long-
De-Wang Ren +5 more
doaj +2 more sources
Classic multivisceral transplant for advanced nonresectable pseudomyxoma peritonei: a case report [PDF]
Journal of Medical Case ReportsBackground Pseudomyxoma peritonei is uncommon with a poorly understood pathogenesis. The standard treatment is cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. However, radical surgical resection is not feasible for patients
Hamed Nikoupour +7 more
doaj +2 more sources
An Ayurvedic intervention for pseudomyxoma peritonei - A case report [PDF]
Journal of Ayurveda and Integrative MedicineCancer is the deadliest disease in the world and cancer treatment remains as a challenge among all systems of medicine. Pseudomyxoma peritonei is one of the rarest malignancies, devoid of any promising management strategies.
Divya Sukumar +4 more
doaj +2 more sources
South African Journal of Radiology, 2014 Pseudomyxoma peritonei is a rare complication of mucinous tumours of appendiceal or ovarian origin. Other associations are malignancies of the colon, urachus and biliary tree.
Binit Sureka +4 more
doaj +3 more sources
The American Journal of the Medical Sciences, 2010 Pseudomyxoma peritonei (PMP) is an uncommon "borderline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists regarding the pathological classification and its prognostic value. Computed
Ming-Jong, Bair +3 more
+8 more sources
High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies [PDF]
Pleura and PeritoneumPseudomyxoma peritonei (PMP) is a rare, slow-growing cancer with few efficacious treatment options in unresectable cases. Mutations in the KRAS and GNAS oncogenes are common, but the reported frequencies vary greatly, most likely because of low tumor ...
Torgunrud Annette +6 more
doaj +2 more sources
Pseudomyxoma pleurii: unusual location of a rare disease
Radiology Case Reports, 2021 Pseudomyxoma peritonei with pleural extension is very rare. Dissemination in the pleural cavity can be trans diaphragmatic or hematogenous. Appendicular and ovarian mucinous tumors are the most often involved.
Kaoutar Imrani +4 more
doaj +1 more source
Surgery, 2002 Abstract Pseudomyxoma peritonei is a relatively rare and poorly understood condition in which mucus accumulates within the peritoneal cavity. The presence of cells in the mucin, either inflammatory or neoplastic, distinguishes it from simple acellular mucus ascites caused by mucinous spillage.
Hani, Baradi, Jeffrey, Ponsky
openaire +4 more sources
Inguinal Hernia as an Initial Presentation of Pseudomyxoma Peritonei [PDF]
Journal of Clinical and Diagnostic Research, 2017 Pseudomyxoma Peritonei (PMP) is characterized by presence of abundant extracellular mucin in the peritoneum. Preoperative diagnosis of pseudomyxoma peritonei is difficult due to its varied presentation.
Biswajit Dey +4 more
doaj +1 more source